The FDA has approved Gvoke VialDx (glucagon) for IV use as a diagnostic aid during radiologic examinations to temporarily inhibit movement of the GI tract.

Bio-Thera Solutions, the developer of the biosimilar, will continue to hold manufacturing rights in the US market.

Vadodara: Alembic Pharmaceuticals Limited has announced that it has received Final Approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application ...

Alembic Pharmaceuticals has received Final Approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDAPantoprazole Sodium for Injection, 40 mg/vial ...

Originally approved by the FDA in September 2023, Biogen's Tofidence became the first tocilizumab biosimilar available in the ...

Tofidence is indicated in certain patients for the treatment of moderate to severe rheumatoid arthritis, giant cell arteritis ...

Organon (OGN) announced that it has acquired from Biogen (BIIB) regulatory and commercial rights in the U.S. for Tofidence, a biosimilar to ...

The injection is also prescribed for pathological hypersecretion conditions, including Zollinger-Ellison (ZE) Syndrome.

According to IQVIA data, the estimated market size for Pantoprazole Sodium for Injection in the US was $48 million for the ...

Health officials in Kansas say a measles outbreak in the state that has expanded to 23 cases may be liked to a larger ...

We recently published a list of 12 Popular Penny Stocks on Robinhood to Watch. In this article, we are going to take a look at where Gossamer Bio Inc.

The travel vial kept well in my purse during the week ... The capsules themselves are substantial in size and the two pill ...